Profiling B-type natriuretic peptide in a stable heart failure population: A valuable adjunct to care

Irish Journal of Medical Science

Volumn 180, Issue 2, 2011, Pages 355-362

  Jan, A ^a   Murphy, N F ^a   O'Loughlin, C ^a   Ledwidge, M ^a   McDonald, K ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

B type natriuretic peptide; Disease management programme; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; ARTICLE; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 79955611341     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-011-0689-1     Document Type: Article

References (39)

1. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50:2357-2368 (Pubitemid 50011582)
2. Logeart D, Thabut G, Jourdain P et al (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 43:635-641 (Pubitemid 38229537)
3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49:1943-1950 (Pubitemid 46694287)
4. Yu CM, Sanderson JE (1999) Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1:59-65 (Pubitemid 30074676)
5. Ishii J, Nomura M, Nakamura Y et al (2002) Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89:691-695 (Pubitemid 34230565)
6. Cournot M, Leprince P, Destrac S, Ferrieres J (2007) Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure. Am J Geriatr Cardiol 16:8-14
7. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38:1934-1941
8. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C (2004) B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 43:1584-1589 (Pubitemid 38561337)
9. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330:625
10. Jourdain P, Jondeau G, Funck F et al (2007) Plasma brain natriuretic peptide guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733-1739 (Pubitemid 46589928)
11. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126-1130 (Pubitemid 30172933)
12. Castellanos LR, Bhalla V, Isakson S, et al (2008) B-type Natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events. J Card Fail (article in press)
13. O'Hanlon R, O'Shea P, Ledwidge M et al (2007) The biologic variability of B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail 13:50-55 (Pubitemid 46330833)
14. Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR (2007) Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail 9:68-74 (Pubitemid 46074482)
15. Moertl D, Berger R, Hammer A et al (2009) B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure. J Card Fail 15:233-240
16. Wei T, Zeng C, Chen L et al (2005) Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 59:891-894
17. McDonald K, Ledwidge M, Cahill J et al (2002) Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail 8:142-148 (Pubitemid 34857279)
18. Ledwidge M, Ryan E, O'Loughlin C et al (2005) Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs. Eur J Heart Fail 7:385-391 (Pubitemid 40249530)
19. Nieminen MS, Böhm M, Cowie MR et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26:384-416 (Pubitemid 40283098)
20. Cheng V, Kazanagra R, Garcia A et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386-391
21. Hosmer D, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. John Wiley & Sons, Inc, New York
22. Maeda K, Tsutamoto T, Wada A et al (2000) High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36:1587-1593
23. Rienstra M, Van GI, Van den Berg MP, Boomsma F, van Veldhuisen DJ (2006) Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-) ANP and (NT-pro) BNP. Europace 8:482-487
24. Watanabe J, Shiba N, Shinozaki T et al (2005) Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail 11:50-55 (Pubitemid 40215314)
25. Berger R, Huelsman M, Strecker K et al (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105:2392-2397 (Pubitemid 34556391)
26. Valle R, Aspromonte N, Feola M et al (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11:498-503 (Pubitemid 41403272)
27. Aspromonte N, Feola M, Milli M et al (2007) Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure. Diabet Med 24:124-130 (Pubitemid 46174934)
28. Verdiani V, Nozzoli C, Bacci F et al (2005) Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 7:566-571 (Pubitemid 40732988)
29. Christ M, Laule-Kilian K, Hochholzer W et al (2006) Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol 48:1808-1812 (Pubitemid 44648609)
30. Harrison A, Morrison LK, Krishnaswamy P et al (2002) B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39:131-138 (Pubitemid 34118942)
31. Anand IS, Fisher LD, Chiang YT et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278-1283 (Pubitemid 36314411)
32. Wijeysundera HC, Hansen MS, Stanton E et al (2003) Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J 146:291-297 (Pubitemid 36951774)
33. Ryder M, Murphy NF, McCaffrey D, O'Loughlin C, Ledwidge M, McDonald K (2008) Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail 10:267-272
34. Conlon C, O'Loughlin C, Ledwidge M, McDonald K (2006) Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration: Effectiveness and Impact on the Workload Pattern of a Hospital-Based Heart Failure Unit. Dis Manage Health Outcomes 14:185-190 (Pubitemid 43927062)
35. Miller WL, Hartman KA, Burritt MF et al (2007) Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 116:249-257 (Pubitemid 47196560)
36. Bettencourt P, Frioes F, Azevedo A et al (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 93:45-48 (Pubitemid 38068508)
37. Masson S, Latini R, Anand IS et al (2008) Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 52:997-1003
38. Maeder MT, Hack D, Rickli H et al (2008) Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure. Wien Klin Wochenschr 120:672-678
39. Pfisterer M, Buser P, Rickli H et al (2009) BNP-Guided vs Symptom-Guided Heart Failure Therapy The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial. JAMA 301:383-392